Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States. (Record no. 28971747)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02216 a2200661 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518003901.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201908s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1941-3297 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1161/CIRCHEARTFAILURE.118.005400 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | DeVore, Adam D |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20190813 |
245 00 - TITLE STATEMENT | |
Title | Patient, Provider, and Practice Characteristics Associated With Sacubitril/Valsartan Use in the United States. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Circulation. Heart failure |
Date of publication, distribution, etc. | 09 2018 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | e005400 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Ambulatory Care |
General subdivision | trends |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aminobutyrates |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Angiotensin II Type 1 Receptor Blockers |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Biphenyl Compounds |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clinical Decision-Making |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Combinations |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Guideline Adherence |
General subdivision | trends |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Heart Failure |
General subdivision | diagnosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neprilysin |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Patient Selection |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Patients |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Practice Guidelines as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Practice Patterns, Physicians' |
General subdivision | standards |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protease Inhibitors |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Registries |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Specialization |
General subdivision | trends |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Tetrazoles |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Time Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | United States |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Valsartan |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hill, C Larry |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Thomas, Laine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sharma, Puza P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Albert, Nancy M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Butler, Javed |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Patterson, J Herbert |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Spertus, John A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Williams, Fredonia B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Duffy, Carol I |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | McCague, Kevin |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hernandez, Adrian F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fonarow, Gregg C |
773 0# - HOST ITEM ENTRY | |
Title | Circulation. Heart failure |
Related parts | vol. 11 |
-- | no. 9 |
-- | p. e005400 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1161/CIRCHEARTFAILURE.118.005400">https://doi.org/10.1161/CIRCHEARTFAILURE.118.005400</a> |
Public note | Available from publisher's website |
No items available.